Bavarian Nordic A/S logo

Bavarian Nordic A/S

OCSE:BAVA (Denmark)  
kr 180.75 (-0.85%) Jun 7
14.01
P/B:
1.38
Market Cap:
kr 14.07B ($ 2.04B)
Enterprise V:
kr 11.91B ($ 1.72B)
Volume:
159.46K
Avg Vol (2M):
444.21K
Also Trade In:
Volume:
159.46K
Avg Vol (2M):
444.21K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Bavarian Nordic A/S ( ) from 1998 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bavarian Nordic A/S stock (OCSE:BAVA) PE ratio as of Jun 09 2024 is 14.01. More Details

Bavarian Nordic A/S (OCSE:BAVA) PE Ratio (TTM) Chart

To

Bavarian Nordic A/S (OCSE:BAVA) PE Ratio (TTM) Historical Data

Total 1262
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Bavarian Nordic A/S PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-09 14.0 2024-04-02 12.6
2024-06-07 14.0 2024-03-27 8.0
2024-06-06 14.1 2024-03-26 8.0
2024-06-04 14.1 2024-03-25 7.9
2024-06-03 14.4 2024-03-22 8.0
2024-05-31 14.3 2024-03-21 8.1
2024-05-30 13.8 2024-03-20 8.0
2024-05-29 13.6 2024-03-19 8.1
2024-05-28 13.8 2024-03-18 8.1
2024-05-27 13.9 2024-03-15 8.2
2024-05-24 13.9 2024-03-14 8.4
2024-05-23 13.8 2024-03-13 8.5
2024-05-22 13.8 2024-03-12 8.7
2024-05-21 13.4 2024-03-11 8.5
2024-05-17 13.9 2024-03-08 8.9
2024-05-16 13.4 2024-03-07 8.6
2024-05-15 13.3 2024-03-06 8.1
2024-05-14 13.0 2024-03-05 7.7
2024-05-13 12.8 2024-03-04 7.8
2024-05-08 12.6 2024-03-01 8.0
2024-05-07 12.6 2024-02-29 8.0
2024-05-06 12.4 2024-02-28 8.2
2024-05-03 12.1 2024-02-27 8.5
2024-05-02 11.8 2024-02-26 9.1
2024-05-01 11.8 2024-02-23 9.0
2024-04-30 11.9 2024-02-22 8.9
2024-04-29 11.8 2024-02-21 8.6
2024-04-26 11.5 2024-02-20 8.8
2024-04-25 11.2 2024-02-19 8.6
2024-04-24 11.6 2024-02-16 8.3
2024-04-23 11.7 2024-02-15 8.3
2024-04-22 11.6 2024-02-14 8.0
2024-04-19 11.4 2024-02-13 8.0
2024-04-18 11.4 2024-02-12 8.3
2024-04-17 11.6 2024-02-09 8.0
2024-04-16 11.8 2024-02-08 8.1
2024-04-15 11.9 2024-02-07 8.0
2024-04-12 11.7 2024-02-06 8.0
2024-04-11 11.8 2024-02-05 7.9
2024-04-10 11.7 2024-02-02 7.9
2024-04-09 11.7 2024-02-01 7.9
2024-04-08 11.7 2024-01-31 8.2
2024-04-05 11.9 2024-01-30 8.1
2024-04-04 12.2 2024-01-29 8.0
2024-04-03 12.7 2024-01-26 8.0

Bavarian Nordic A/S (OCSE:BAVA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Bavarian Nordic A/S is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.